Founder leverages Claude AI to decode lymphoma scan and steer treatment
Founder Connor Christou fed his blood work, scans, wearables and journal notes into Claude, which flagged a thymus rebound that mimics disease in young lymphoma patients. That insight helped him avoid a false‑positive scan and choose a more aggressive chemo regimen, boosting his survival odds. It shows how AI can turn personal health data into actionable medical intelligence.